Home
Account
Research Tools
Educate
Contribute
News
Sectors
Premium
About Us
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Chart School
Tutorials
Learning Center
Glossary
Submit Article
Join Blog Network
Rate Broker
Rate Software
Earnings
Dividend
Management Changes
M&A
Analyst
FDA
IPO
About Us
Contact Us
Advertise With Us
Editorial Staff
Terms and Conditions
Privacy Policy
iStock Rating
F
Details...
Enter Symbol
Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN)
Sector: Medical
Current Price :
$30.98
52 Week Low
$8.26
52 Week High
$30.98
Company
Overview
Research Notes
Company Profile
Competitors
Community
Stock Sentiment
Whisper Estimates
Enter Estimates
Message Board
Analysis
Blog Articles
Press Releases
Charts
Technical Charts
Analyst
Analyst Ratings
Analyst Estimates
Sales Estimates
Ratios
Financial Ratios
Technicals
Shares Outstanding:
162M
Market Cap:
$5.04B
Avg Volume:
10775931
P/E Ratio:
-0.010
PEG Ratio:
-0.010
1m
3m
6m
1y
2y
Opinion and Analysis
The Rebirth Of Equities Starts With These Stocks
Sep 07, 2012 03:12 PM |
AAPL
,
AMLN
,
BMY
,
INHX
,
ORCL
,
SAP
The Rebirth Of Equities Starts With These Stocks
Aug 29, 2012 12:32 PM |
AAPL
,
AMLN
,
BMY
,
INHX
,
ORCL
,
SAP
Onyx Pharma (ONXX): An Attractive Takeover Target After Kyprolis Approval
Jul 25, 2012 06:06 PM |
AMLN
,
GSK
,
ONXX
More Articles on AMLN..
Press Releases
Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.
Aug 01, 2012 07:30 AM |
AMLN
,
BMY
The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Amylin Pharmaceuticals, Inc. in Connection with the Sale of the Company to Bristol-Myers Squibb Corporation
Jul 11, 2012 06:10 PM |
AMLN
Block & Leviton LLP Investigates Amylin Pharmaceuticals, Inc. for Possible Breaches of Fiduciary Duties in Connection with Its Proposed Merger with Bristol-Myers Squibb Company
Jul 10, 2012 12:01 PM |
AMLN
,
BMY
More Press Releases on AMLN..
SEC Filings
Form 4 AMYLIN PHARMACEUTICALS For: Jul 25 Filed by: Weyer Christian (10K)
Jul 26, 2012 08:24 PM
Form 4 AMYLIN PHARMACEUTICALS For: Jul 25 Filed by: ROWLAND LLOYD A (10K)
Jul 26, 2012 08:24 PM
Form 4 AMYLIN PHARMACEUTICALS For: Jul 25 Filed by: Mihalik Vincent P (10K)
Jul 26, 2012 08:23 PM
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
AMLN
Compare to S&P
YTD
171.97 %
145.58 %
4 Weeks
9.75 %
7.48 %
12 Weeks
24.20 %
22.24 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-209.09 %
EPS Growth in Last Year:
-41.67 %
Sales Growth in Last Quarter:
-6.82 %
Sales Growth in Last Quarter:
0.64 %
More...
Fundamental data is provided by
Zacks Investment Research
, and Commentary, news and Press Releases provided by YellowBrix and
Quotemedia
. Advertisement partners
Investing Channel
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##